申请人:Kandula Mahesh
公开号:US09108942B1
公开(公告)日:2015-08-18
The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I; and methods for treating or preventing moderate to severe pain, may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of muscle pain, spasticity, neuropathic pain, fibromyalgia, post-operative pain, muscle spasticity, headache, chronic pain, sub-chronic pain and local pain.
该发明涉及公式I的化合物或其药用可接受的盐,以及其多型、溶剂合物、对映体、立体异构体和水合物。包括公式I化合物的有效量的药物组合物;以及用于治疗或预防中度至严重疼痛的方法,可以制备为口服、颊下、直肠、局部、经皮、经粘膜、静脉、肠外、糖浆或注射的给药途径。这样的组合物可用于治疗肌肉疼痛、痉挛、神经痛、纤维肌痛、术后疼痛、肌肉痉挛、头痛、慢性疼痛、亚慢性疼痛和局部疼痛。